Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)

Conditions:   Stroke;   Prevention Interventions:   Drug: Rivaroxaban 2.5 Mg Oral Tablet;   Drug: Rivaroxaban placebo tablets Sponsor:   Mazandaran University of Medical Sciences Not yet recruiting

Source: ClinicalTrials.gov - February 18, 2020 Category: Research Source Type: clinical trials